Related Announcements

RFA-MH-22-110 - Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)

RFA-MH-22-111 - Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)

Issued by

National Institute of Mental Health (NIMH)

Purpose

The National Institute of Mental Health is sponsoring a technical assistance webinar to be held on Tuesday, March 15, 2022 from 1:00 – 2:30 pm (Eastern Time) for all prospective applicants interested in the following companion Funding Opportunity Announcements for the Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes (SSPsyGene) Consortium:

• RFA-MH-22-110 – Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24)
• RFA-MH-22-111 – Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1)

The SSPsyGene Consortium will support multidisciplinary research centers to optimize and implement systematic and scalable approaches for characterizing the developmental, molecular, cellular, systems, and organismal neurobiological function of genes associated with risk for NPDs. These companion awards will be part of a collaborative consortium with the long-term goal of developing a comprehensive phenotypic catalog across biological scales for genes and gene variants associated with neurodevelopmental and psychiatric disorders (NPDs). To accomplish this objective, NIMH intends to establish a consortium of investigators at multiple sites and with broad expertise in the areas of genomics, high throughput technology, and neurobiology. During the webinar, staff from NIMH will provide an overview of RFA-MH-22-110 and RFA-MH-22-111, and answer questions from prospective applicants. Registration for the webinar is required (see link below).

All prospective applicants are invited to attend and are highly encouraged to submit general questions in advance to maximize the use of time. Specific questions should be sent via email to SSPsyGene@mail.nih.gov by 1:00 pm EST on March 8, 2022. While an effort will be made to prioritize and include all questions in the webinar, it is possible that not all questions will be addressed during the event.

Webinar Information

The webinar will be hosted through Zoom.

Date: March 15, 2022

Time: 1:00 to 2:30 p.m. Eastern Time (ET)

Registration is required to attend the webinar: Register here

Participation in the webinar is optional and is not required for the submission of an application in response to any of the related announcements listed in the Notice.

Prospective applicants who are unable to participate in the webinar are encouraged to view the frequently asked questions (FAQs). These will be made available on the NIMH website approximately one week after the event.

If you have questions about the webinar, please email SSPsyGene@mail.nih.gov.

Participants requiring sign language interpretation and/or other reasonable accommodations should contact SSPsyGene@mail.nih.gov at least 5 days prior to the event.

Inquiries

Please direct all inquiries to:

Email: SSPsyGene@mail.nih.gov